Cost-of-illness of COPD in Germany

D. Nowak, P. Oberender, K. Ueberla, A. Spannheimer, C. Schlegel, U. Reitberger, R. Welsch, S. Ruckdaeschel (Munich, Bayreuth, Ingelheim am Rhein, Karlsruhe, Germany)

Source: Annual Congress 2003 - Management of COPD in primary care
Session: Management of COPD in primary care
Session type: Oral Presentation
Number: 2433
Disease area: Airway diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
D. Nowak, P. Oberender, K. Ueberla, A. Spannheimer, C. Schlegel, U. Reitberger, R. Welsch, S. Ruckdaeschel (Munich, Bayreuth, Ingelheim am Rhein, Karlsruhe, Germany). Cost-of-illness of COPD in Germany. Eur Respir J 2003; 22: Suppl. 45, 2433

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
ILD registries in Germany: INSIGHTS-IPF
Source: International Congress 2016 – Interstitial lung disease registry
Year: 2016


Real-world treatment of incident COPD patients in Germany
Source: Virtual Congress 2021 – Inhaled treatments for COPD: real-world data
Year: 2021


Co-morbidities in patients with COPD in the UK
Source: Eur Respir J 2003; 22: Suppl. 45, 375s
Year: 2003

Costs of COPD and asthma in Sweden
Source: Eur Respir J 2004; 24: Suppl. 48, 701s
Year: 2004

Economic burden of bronchiectasis in Germany
Source: Eur Respir J, 53 (2) 1802033; 10.1183/13993003.02033-2018
Year: 2019



Real-life evaluation of budesonide/formoterol (DuoResp Spiromax) for the management of asthma and COPD in the UK
Source: International Congress 2017 – Primary care diagnosis, assessment and management of COPD
Year: 2017


The DACCORD study: Real-life COPD outpatient treatment with long-acting bronchodilators in Germany
Source: Annual Congress 2013 –Treatment and adherence to treatment of respiratory disease
Year: 2013

Co-morbid asthma in COPD patients in the UK
Source: Annual Congress 2010 - Comorbidity in obstructive airway disease
Year: 2010

Healthcare costs and resource use in patients with chronic obstructive pulmonary disease (COPD) in Ontario, Canada
Source: Virtual Congress 2021 – Primary care organisation and epidemiology
Year: 2021


COPD medications and risk of pneumonia in the UK
Source: Annual Congress 2008 - COPD - clinical and epidemiological aspects
Year: 2008

Outcomes of COPD exacerbations - a report from the ERS COPD audit in Austria
Source: Annual Congress 2013 –COPD: acute exacerbations and others
Year: 2013


Underdiagnosis and misclassification of COPD in Sweden
Source: Virtual Congress 2020 – Risk factors for chronic lung diseases
Year: 2020


COPD
Source: ERS Skills Course 2016
Year: 2016

COVID-19 and COPD
Source: Eur Respir J, 56 (2) 2002108; 10.1183/13993003.02108-2020
Year: 2020



COPD
Source: ERS Lung Science Conference 2016
Year: 2016




COPD
Source: ERS Skills Course 2017 - Summer school of adult respiratory medicine
Year: 2017

COPD
Source: Eur Respir Monogr 2017; 77: 147-166
Year: 2017


COPD
Source: ERS Course 2018 - Summer school of adult respiratory medicine
Year: 2018